Search results
Shark Tank India's Namita Thapar to make a whopping amount of around Rs 127cr from her brand's IPO...
The Times of India· 6 days agoShark Tank India's Namita Thapar is to receive a whopping of around Rs 127 cr from her recent...
Meet Namita Thapar, Shark Tank Judge Who is Raking in Nearly Rs 128 Crore via Emcure Pharma IPO -...
News18· 4 days agoNamita Thapar is a remarkably successful businesswoman who is also an investor on Shark Tank India...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 6 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 5 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 7 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on ...
Who Is Namita Thapar, Shark Tank Judge Set To Earn Rs 127 Crore From IPO
NDTV· 5 days agoEntrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in...
Emcure has better listed pharma alternatives
The Economic Times· 5 days agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical ...
Namita Thapar may gain ₹127 crore in Emcure Pharma IPO
Hindustan Times· 7 days agoThrough the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 6 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 5 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...